Projects per year
Fingerprint Dive into the research topics where Mark Slifka is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Projects
Pacific NorthWest Regional Center of Excellence (PNWRCE)
Streblow, D., Slifka, M., McWeeney, S., Axthelm, M., Moses, A., Nelson, J., Baric, R., Landfear, S., Nikolich-Zugich, J., Barklis, E., Gale, M., Katze, M., Kawaoka, Y., Bevan, M., Smith, R., Maizels, N., Frueh, K., Labeaud, A. D., Ryman, K., Chanda, S., Galloway, D. A. & Fruh, K.
4/20/09 → 2/28/15
Project: Research project
Research Output
Advanced oxidation technology for the development of a next-generation inactivated West Nile virus vaccine
Quintel, B. K., Thomas, A., Poer DeRaad, D. E., Slifka, M. & Amanna, I. J., Jan 1 2019, (Accepted/In press) In : Vaccine.Research output: Contribution to journal › Article
1
Scopus
citations
An observer blinded, randomized, placebo-controlled, phase I dose escalation trial to evaluate the safety and immunogenicity of an inactivated West Nile virus Vaccine, HydroVax-001, in healthy adults
Woods, C. W., Sanchez, A. M., Swamy, G. K., McClain, M. T., Harrington, L., Freeman, D., Poore, E. A., Slifka, D. K., Poer DeRaad, D. E., Amanna, I. J., Slifka, M., Cai, S., Shahamatdar, V., Wierzbicki, M. R., Amegashie, C. & Walter, E. B., Jan 1 2019, (Accepted/In press) In : Vaccine.Research output: Contribution to journal › Article
4
Scopus
citations
Dengue Serostatus and Dengue Vaccine Safety and Efficacy
Slifka, M. & Amanna, I. J., Nov 15 2018, In : The New England journal of medicine. 379, 20, 1 p.Research output: Contribution to journal › Letter
4
Scopus
citations